drugset / Trial / NCT00810212
Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate safety and preliminary efficacy of Neofusetm in subjects with a diagnosis of degenerative disc disease (DDD) in 1 or 2 adjacent vertebral levels between L1 and S1 and undergoing posterolateral lumbar fusion.
Timeline
- Start
- 2008-11
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rexlemestrocel-L | Cell therapy | 2.5e+07 cells | — |
| Subject | Rexlemestrocel-L | Cell therapy | 5e+07 cells | — |
| Subject | Rexlemestrocel-L | Cell therapy | 7.5e+07 cells | — |